首页|MRI基于2023版国际妇产科联盟分期评估子宫内膜癌进展

MRI基于2023版国际妇产科联盟分期评估子宫内膜癌进展

扫码查看
子宫内膜癌(EC)是常见妇科恶性肿瘤;MRI对EC评估具有重要价值.2023年国际妇产科联盟(FIGO)分期做出重大修订,以更细致地对EC进行风险分层,也使MRI面临新的挑战.本文就MRI基于2023版FIGO分期评估EC进展进行综述.
Progresses of MRI evaluating endometrial cancer based on 2023 International Federation of Gynecology and Obstetrics staging
Endometrial cancer(EC)is a common gynecological malignancy.MRI plays an important role for evaluation of EC.In 2023,International Federation of Gynecology and Obstetrics(FIGO)staging was significantly modified to perform more detailed risk stratification of EC,which brought new challenges to MRI.The progresses of MRI for evaluating EC based on 2023 FIGO staging were reviewed in this article.

endometrial neoplasmsneoplasm stagingmagnetic resonance imaging

刘晓怡、王珂、苟心怡、王屹、洪楠、程瑾

展开 >

北京大学人民医院放射科,北京 100044

子宫内膜肿瘤 肿瘤分期 磁共振成像

2024

中国医学影像技术
中国科学院声学研究所

中国医学影像技术

CSTPCD北大核心
影响因子:0.763
ISSN:1003-3289
年,卷(期):2024.40(4)
  • 28